Loading...
Loading...
African Journal of Biology and Medical Research
Vol. 6Issue 12023pp. 24–34Published 23 January 2023
DOI 10.52589/AJBMR-VLJJRYIMShare Link
Cite this
Citation unavailable for this article.
Abstract:
In order to contribute to the knowledge of the effects of antiretroviral drugs, a descriptive study was conducted on HIV patients who started antiretroviral therapy (ART). The 321 patients who were the subject of this study were selected from the cohort of HIV-infected patients followed at the Centre Médical de Suivi des Donateurs de Sang (CMSDS) in Abidjan (RCI), in the period from 2005 to 2012. These patients received regularly, according to their condition, seven (7) ARV therapeutic combinations which are AZT-3TC-EFV, AZT-3TC-NVP, AZT-3TC-NFV, AZT-3TC-LOP/RIT, DT4-3TC-EFV, DT4-3TC-NVP, and FTC-TDF-EFV. Biological check-ups performed every six (6) months allowed to follow these patients during 36 months of treatment and biological parameters were measured. The results on transaminases (GOT, GPT) and creatinine do not show toxicity of these different treatments on the hepatic and renal functions.
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights